Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04105504Phase 1Completed
Phase 1, randomised, double-blind trial comparing Glutathione Group with Placebo Group (2 arms). Primary endpoints: Change from Baseline Spot UV at 12 weeks, Change from Baseline Spot Polarization at 12 weeks and 1 more. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04105504.